Zaiding Medicine: Clinical study of KarXT for the treatment of schizophrenia completed, enrolled patients from mainland China
六月清晨搅
发表于 2024-8-13 15:04:02
221
0
0
On August 13th, Zaiding Pharmaceutical announced that the UNITE-1 study of KarXT (Xanomeline Tropium) for schizophrenia has completed the enrollment of all mainland Chinese patients. Zaiding Pharmaceutical is expected to obtain key research data from 2024 to the first half of 2025 and submit a new drug application for KarXT for schizophrenia in mainland China.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
转播
You may like
- Starting from December 1st, Microsoft Copilot will be open to mainland users
- "Fruit Chain" Big Turn: Apple Vision Pro is about to be mass-produced, with the supply chain proportion in mainland China significantly increasing to 60%
- Bristol Myers Squibb announces acquisition of schizophrenia drug manufacturer Karuna for $14 billion
- On site visit to Costco's first gas station in mainland China: 50% off oil prices, member store "cross-border coupons"
- Longest Clinical Study of Smegglutide Published: Continuous Four Years of Medication Can Maintain 10% Weight Loss
- AstraZeneca: Clinical studies have shown that targeted anti-cancer drug Teresa can prolong progression free survival by more than 3 years
- Johnson&Johnson Long acting Schizophrenic Therapy Approved in China
- How is the progress of the world's first new drug for schizophrenia approved in the US and in the Chinese market
- The total number of Starbucks stores in mainland China has reached 7596
- McDonald's has over 6700 restaurants in mainland China
